Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) T.ATE

Alternate Symbol(s):  ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


TSX:ATE - Post by User

Comment by TriumphSpitSixon Jun 22, 2020 2:07am
315 Views
Post# 31175438

RE:RE:just relax

RE:RE:just relaxYou don't know sh!t, Lebowski. There has been beaucoupbeaucoupbeaucoup money made here over the years with the multiple ups and downs on news since Ph.1. I have bought and am rehabbing a 3-unit rental property funded entirely with Antibe and Pyrogenesis profits, so you can suck it, FUDfairy.

AlbertaGuy9 wrote: SELL HIGH BUY LOW -INSIDERS MOTTO - Insiders successfull to manage the Investor HERD for Half a Decade.

Same Stock Price since PAST 6 years. Haywood securities is Insiders firm which manipulates this stock. I submitted Insiders Trading complaint to IIROC. I recieved acknowledgement. Will see what happens.

No HALT for very important news of Phase 2 results release?
But Halt for Offering? 
CEO and CMO dumping shares while Conference call! SHAMELESS PUMPERS IGNORE THIS.

This is NOT Volatality. This is called RINSE and REPEAT. I will help you why this stock is around this sampe price range since past 6 years:

https://thedeepdive.ca/antibe-therapeutics-posts-positive-study-results-insiders-unload-positions/

and

https://antibethera.com/news/antibe-therapeutics-announces-25-million-bought-deal-unit-offering/


Well there are number of CON-ARTISTs posing as Investors on this board who are posting BS  are actually traders. 

No Partnerships gonna Happen - No Nasdaq- BUT More Selling and offerings.

AKA PUMP and DUMP.

Jefnan1 wrote: what are you expecting Albertaguy from a small company trying to develop a new drug, I think it would be more surprising if there was no volatility. With a situation like this you either bet they will win and hold on until the end or invest your funds in any other type of mature situation where the movement in the share price can be determined by traditional analysis.




<< Previous
Bullboard Posts
Next >>